RSA's attempt to swallow up large swathes of Aviva's non-life business in a transformational multi-billion pound deal looks like a long shot, according to analysts.
RSA's attempt to swallow up large swathes of Aviva's non-life business in a transformational multi-billion pound deal looks like a long shot, according to analysts.